Treatment of hepatitis c with thymosin and pegylated interferon

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 38/21 (2006.01) A61K 38/22 (2006.01)

Patent

CA 2418154

A method and pharmaceutical combination for treating hepatitis C by administering to a hepatitis C patient an effective amount of at least one thymosin or an effective amount of at least thymosin fragment, in combination with administration to the hepatitis C patient of an effective amount of at least one pegylated interferon.

L'invention concerne un procédé et une combinaison pharmaceutique pour traiter l'hépatite C par administration à un patient souffrant de cette hépatite d'une quantité efficace d'au moins une thymosine ou une quantité efficace d'au moins un fragment de thymosine, en combinaison avec l'administration audit patient d'une quantité efficace d'au moins un PEG-interféron.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Treatment of hepatitis c with thymosin and pegylated interferon does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of hepatitis c with thymosin and pegylated interferon, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of hepatitis c with thymosin and pegylated interferon will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1940413

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.